The use of methotrexate in conservative treatment of placenta accreta spectrum disorders.

This article reports on a series of patients with placenta accreta spectrum (PAS) disorder who were treated conservatively with Methotrexate (MTX) administration with or without embolization. We investigate whether there is a place for MTX in conservative treatment of PAS. We present a single-center retrospective case series of five patients.